Moors & Cabot
IBB icon

Moors & Cabot’s iShares Biotechnology ETF IBB Stock Holding History

Moors & Cabot’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-30,000
Closed -$30K – 656
2019
Q3 		$30K Buy
+30,000
New +$3.14M ﹤0.01% 625

Other funds holding IBB

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Commerce Bank
Commerce Bank Kansas City, Missouri $22.9B AUM 22.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return

Moors & Cabot's IBB Position: Q3 2026 in Review

Moors & Cabot reduced its iShares Biotechnology ETF (IBB) stake by 0.65% in Q3 2026, selling an estimated $11.8K and leaving 9,062 shares worth $1.91M. The position accounts for 0.07% of the portfolio, ranked #247.

Moors & Cabot first reported a position in IBB in Q1 2014 and has held it in 45 quarters since. The position peaked at $4.57M in Q2 2021. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Moors & Cabot held 9,062 shares of iShares Biotechnology ETF worth $1.91M as of Q3 2026.
  • Moors & Cabot sold 59 iShares Biotechnology ETF shares in Q3 2026, an estimated $11.8K.
  • iShares Biotechnology ETF made up 0.07% of Moors & Cabot's portfolio in Q3 2026, its #247 holding.
  • Moors & Cabot first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 45 quarters since.
  • Moors & Cabot's iShares Biotechnology ETF position peaked at $4.57M in Q2 2021.
  • 907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Moors & Cabot's 13F filing for Q3 2026, filed 6 Nov 2026.